Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2016-11-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1617789113PMID 27872306PMCID PMC5150408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay

  2017cited by this paper
• Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo

  2016cited by this paper
• Defective proviruses rapidly accumulate during acute HIV-1 infection

  2016cited by this paper
• Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.

  2016cited by this paper
• Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.

  2016cited by this paper
• Elimination of HIV-1-infected cells by broadly neutralizing antibodies

  2016cited by this paper
• HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

  2016cited by this paper
• B-108 Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

  2016influential reference
• Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo

  2016cited by this paper
• Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality

  2016cited by this paper
• Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.

  2016cited by this paper
• What Integration Sites Tell Us about HIV Persistence.

  2016cited by this paper
• HIV-1 Reservoirs During Suppressive Therapy.

  2016cited by this paper
• Broad activation of latent HIV-1 in vivo

  2016cited by this paper
• Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies.

  2015influential reference
• HIV-1 integration landscape during latent and active infection.

  2015cited by this paper
• HIV reservoirs: what, where and how to target them

  2015cited by this paper
• Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

  2015cited by this paper
• HIV reservoirs as obstacles and opportunities for an HIV cure

  2015cited by this paper
• Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy.

  2015cited by this paper
• The Remarkable Stability of the Latent Reservoir for HIV-1 in Resting Memory CD4+ T Cells.

  2015cited by this paper
• HIV-1 Virion Production from Single Inducible Proviruses following T-Cell Activation Ex Vivo

  2015cited by this paper
• Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice.

  2014cited by this paper
• Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

  2014cited by this paper
• Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

  2014influential reference
• Global epistasis makes adaptation predictable despite sequence-level stochasticity

  2014cited by this paper
• Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

  2013cited by this paper
• The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time

  2013cited by this paper
• Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies

  2013cited by this paper
• An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells

  2012cited by this paper
• Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

  2012cited by this paper
• Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection

  2012cited by this paper
• The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients

  2012cited by this paper
• HIV latency.

  2011cited by this paper
• Clonal Sequences Recovered from Plasma from Patients with Residual HIV-1 Viremia and on Intensified Antiretroviral Therapy Are Identical to Replicating Viral RNAs Recovered from Circulating Resting CD4+ T Cells

  2011cited by this paper
• HIV reservoirs and the possibility of a cure for HIV infection

  2011cited by this paper
• Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes.

  2011cited by this paper
• New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0.

  2010cited by this paper
• Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

  2009cited by this paper
• A Genealogical Approach to Quantifying Lineage Divergence

  2008influential reference
• Isolation and propagation of HIV-1 on peripheral blood mononuclear cells

  2008cited by this paper
• HIV rebounds from latently infected cells, rather than from continuing low-level replication

  2008cited by this paper
• A weakly informative default prior distribution for logistic and other regression models

  2008cited by this paper
• Slow Human Immunodeficiency Virus Type 1 Evolution in Viral Reservoirs in Infants Treated with Effective Antiretroviral Therapy

  2007cited by this paper
• RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models

  2006cited by this paper
• Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

  2005cited by this paper
• Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays

  2004cited by this paper
• APE: Analyses of Phylogenetics and Evolution in R language

  2004cited by this paper
• Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

  2003cited by this paper
• Evolution of Envelope Sequences of Human Immunodeficiency Virus Type 1 in Cellular Reservoirs in the Setting of Potent Antiviral Therapy

  1999cited by this paper
• Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

  1999cited by this paper
• Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

  1998cited by this paper
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

  1997cited by this paper
• Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

  1997influential reference
• In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency

  1995cited by this paper
• HIV Latency

  1993cited by this paper

• Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.

  2026cites this paper
• The Differentially Regulated Cousins: Insights into the Differences in Transcriptional Regulatory Mechanisms Between HTLV-1 and HIV-1

  2026cites this paper
• Tools to Quantify and Characterize the Persistent Reservoir in People with HIV-1: Focus on Non-B Subtypes

  2026cites this paper
• Transcription of HIV-1 is heterogenous among authentic latent CD4+ T cell clones.

  2026cites this paper
• Mapping the anatomical distribution and persistence of HIV-infected cell clones in tissues: implications for HIV cure strategies.

  2025cites this paper
• Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies

  2025cites this paper
• Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure

  2025cites this paper
• Understanding residual risk of cardiovascular disease in people with HIV

  2025cites this paper
• Current methods for detecting and assessing HIV-1 antibody resistance

  2025cites this paper
• Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places

  2025cites this paper
• HIV Nef amplifies mechanical heterogeneity to promote immune evasion

  2025cites this paper
• Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial

  2025cites this paper
• Mild HIV-specific selective forces overlaying natural CD4+ T cell dynamics explain the clonality and decay dynamics of HIV reservoir cells.

  2025cites this paper
• CD4+ T cells with latent HIV-1 have reduced proliferative responses to T cell receptor stimulation

  2024influential citation
• Transcription of HIV-1 at sites of intact latent provirus integration

  2024influential citation
• Clonal heterogeneity and antigenic stimulation shape persistence of the latent reservoir of HIV

  2024influential citation
• Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission

  2024cites this paper
• Transcription of HIV-1 at sites of intact latent provirus integration

  2024cites this paper
• The cell biology of HIV-1 latency and rebound

  2024cites this paper
• Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies

  2024cites this paper
• HIV Expression in Infected T Cell Clones

  2024cites this paper
• The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time

  2023cites this paper
• Experimental models for HIV latency and molecular tools for reservoir quantification—an update

  2023cites this paper
• Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure

  2023cites this paper
• HIV-PULSE: a long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization

  2023cites this paper
• Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence

  2023cites this paper
• Single-Cell Transcriptomics of Mtb/HIV Co-Infection

  2023cites this paper
• Single-cell multiomic understanding of HIV-1 reservoir at epigenetic, transcriptional, and protein levels

  2023cites this paper
• The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy

  2023cites this paper
• Viral Persistence in the Gut-Associated Lymphoid Tissue and Barriers to HIV Cure

  2023cites this paper
• Humanized Mice for Studies of HIV-1 Persistence and Elimination

  2023cites this paper
• Development of screening assays for use of broadly neutralizing antibodies in people with HIV

  2023cites this paper
• Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants.

  2023cites this paper
• HIV-PULSE: A long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization

  2023cites this paper
• Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia

  2023cites this paper
• Stable HIV Reservoir Despite Prolonged Low-Dose Mycophenolate to Limit CD4+ T-cell Proliferation

  2022cites this paper
• Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency

  2022cites this paper
• HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo

  2022cites this paper
• Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells

  2022cites this paper
• Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV

  2022cites this paper
• Defective HIV-1 genomes and their potential impact on HIV pathogenesis

  2022cites this paper
• Current strategies to induce selective killing of HIV‐1‐infected cells

  2022cites this paper
• Novel assays to investigate the mechanisms of latent infection with HIV-2

  2022cites this paper
• Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies

  2022cites this paper
• Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients

  2022cites this paper
• Viral and Host Biomarkers of HIV Remission Post Treatment Interruption

  2022cites this paper
• Prolonged viral suppression with anti-HIV-1 antibody therapy

  2022cites this paper
• HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies

  2022cites this paper
• Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones.

  2022cites this paper
• Distinct gene expression by expanded clones of quiescent memory CD4+ T cells harboring intact latent HIV-1 proviruses

  2022cites this paper
• Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy

  2022cites this paper
• Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses

  2022cites this paper
• Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption

  2021cites this paper
• Quantifying the clonality and dynamics of the within-host HIV-1 latent reservoir

  2021cites this paper
• Similar Frequency and Inducibility of Intact Human Immunodeficiency Virus-1 Proviruses in Blood and Lymph Nodes

  2021cites this paper
• Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

  2021cites this paper
• Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence

  2021cites this paper
• In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure.

  2021cites this paper
• Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing

  2021cites this paper
• Integration features of intact latent HIV-1 in CD4+ T cell clones contribute to viral persistence

  2021cites this paper
• The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence

  2021cites this paper
• Addressing an HIV cure in LMIC

  2021cites this paper
• Broadly Neutralizing Antibodies for HIV-1 Prevention

  2021cites this paper
• HIV-1 Persistence in Children during Suppressive ART

  2021cites this paper
• HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity

  2021cites this paper
• Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir

  2021cites this paper
• Assessing proviral competence: current approaches to evaluate HIV-1 persistence

  2021cites this paper
• In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia

  2021cites this paper
• Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.

  2021cites this paper
• Single-cell immune profiling reveals the impact of antiretroviral therapy on HIV-1-induced immune dysfunction, T cell clonal expansion, and HIV-1 persistence in vivo

  2021cites this paper
• Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells

  2020cites this paper
• The forces driving clonal expansion of the HIV-1 latent reservoir

  2020cites this paper
• Combination Immune Checkpoint Blockade to Reverse HIV Latency

  2020cites this paper
• Different human resting memory CD4+ T cell subsets show similar low inducibility of latent HIV-1 proviruses

  2020cites this paper
• Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy.

  2020cites this paper
• Advances in Developing CAR T-Cell Therapy for HIV Cure

  2020cites this paper
• Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size

  2020cites this paper
• HIV-1 Viremia Not Suppressible By Antiretroviral Therapy Can Originate from Large T-Cell Clones Producing Infectious Virus

  2020cites this paper
• Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy.

  2020cites this paper
• Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir

  2020influential citation
• Measuring the Success of HIV-1 Cure Strategies

  2020cites this paper
• Improving HIV Outgrowth by Optimizing Cell-Culture Conditions and Supplementing With all-trans Retinoic Acid

  2020cites this paper
• Single-cell transcriptional landscapes reveal HIV-1–driven aberrant host gene transcription as a potential therapeutic target

  2020cites this paper
• HIV-1 Proviral Transcription and Latency in the New Era

  2020cites this paper
• The Atlas of the In Vivo HIV CD4 T Cell Reservoir

  2020cites this paper
• The Paradox of HIV Blood–Brain Barrier Penetrance and Antiretroviral Drug Delivery Deficiencies

  2020cites this paper
• Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA

  2020cites this paper
• Recommendations for measuring HIV reservoir size in cure-directed clinical trials

  2020cites this paper
• Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir

  2020cites this paper
• Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure

  2020cites this paper
• Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Primary African Isolates

  2020cites this paper
• Nonsuppressible HIV-1 viremia: a reflection of how the reservoir persists.

  2020cites this paper
• Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNA

  2020cites this paper
• Heightened resistance to type 1 interferons characterizes HIV-1 at transmission and following analytical treatment interruption

  2020cites this paper
• Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection

  2020cites this paper
• Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1

  2020cites this paper
• Similar frequency and inducibility of intact HIV-1 proviruses in blood and lymph nodes.

  2020cites this paper
• Identification of unrecognized host factors promoting HIV-1 latency

  2020cites this paper
• Antigen-driven clonal selection shapes the persistence of HIV-1 infected CD4+ T cells in vivo

  2020cites this paper
• Factors that mold the nuclear landscape of HIV-1 integration

  2020cites this paper